1. Home
  2. TENX vs NINE Comparison

TENX vs NINE Comparison

Compare TENX & NINE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • NINE
  • Stock Information
  • Founded
  • TENX 1967
  • NINE 2011
  • Country
  • TENX United States
  • NINE United States
  • Employees
  • TENX N/A
  • NINE N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • NINE Oilfield Services/Equipment
  • Sector
  • TENX Health Care
  • NINE Energy
  • Exchange
  • TENX Nasdaq
  • NINE Nasdaq
  • Market Cap
  • TENX 27.3M
  • NINE 29.8M
  • IPO Year
  • TENX N/A
  • NINE 2018
  • Fundamental
  • Price
  • TENX $6.37
  • NINE $0.69
  • Analyst Decision
  • TENX Strong Buy
  • NINE
  • Analyst Count
  • TENX 4
  • NINE 0
  • Target Price
  • TENX $16.67
  • NINE N/A
  • AVG Volume (30 Days)
  • TENX 47.8K
  • NINE 608.0K
  • Earning Date
  • TENX 11-12-2025
  • NINE 10-30-2025
  • Dividend Yield
  • TENX N/A
  • NINE N/A
  • EPS Growth
  • TENX N/A
  • NINE N/A
  • EPS
  • TENX N/A
  • NINE N/A
  • Revenue
  • TENX N/A
  • NINE $577,300,000.00
  • Revenue This Year
  • TENX N/A
  • NINE $4.56
  • Revenue Next Year
  • TENX N/A
  • NINE $1.41
  • P/E Ratio
  • TENX N/A
  • NINE N/A
  • Revenue Growth
  • TENX N/A
  • NINE 3.23
  • 52 Week Low
  • TENX $3.25
  • NINE $0.44
  • 52 Week High
  • TENX $7.89
  • NINE $1.87
  • Technical
  • Relative Strength Index (RSI)
  • TENX 69.69
  • NINE 51.11
  • Support Level
  • TENX $6.02
  • NINE $0.64
  • Resistance Level
  • TENX $6.50
  • NINE $0.74
  • Average True Range (ATR)
  • TENX 0.15
  • NINE 0.04
  • MACD
  • TENX 0.04
  • NINE 0.01
  • Stochastic Oscillator
  • TENX 78.56
  • NINE 48.54

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About NINE Nine Energy Service Inc.

Nine Energy Service Inc is a North American onshore completion and production services provider. It targets unconventional oil and gas resource development. It operates in one segment, Completion Solutions. The Completion Solutions segment offers cementing services; completion tools, including liner hangers and accessories, frac sleeves, fully composite frac plugs, and specialty open hole float equipment and centralizers and other services. It operates in the U.S, Canada, and other countries where majority of the revenue is generated from the United States.

Share on Social Networks: